Overview
A Study of 18F-AV-45 in Healthy Volunteers
Status:
Completed
Completed
Trial end date:
2008-01-01
2008-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will determine how florbetapir F 18 (18F-AV-45) radioactivity is distributed throughout the body.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Avid Radiopharmaceuticals
Criteria
Inclusion Criteria:- Able to lie still on the imaging table for periods up to 1 hour
Exclusion Criteria:
- Radiation exposure for experimental purposes within the last year
- Claustrophobic or otherwise unable to tolerate the imaging procedure
- Medical condition or surgical history that would confound evaluation
- Current clinically significant cardiovascular disease
- Received an investigational medication within the last 30 days